Applied DNA Sciences, Inc. management will host a conference call beginning at 9:00 a.m. eastern standard time on Friday December 20, 2013 to discuss the company’s performance and outline key ongoing and future business initiatives
STONY BROOK, N.Y. (PRWEB) December 18, 2013
Applied DNA Sciences, Inc. (OTCQB: APDN), a provider of DNA-based security and anti-counterfeiting technology and product authentication solutions, will host a conference call on Friday December 20, 2013 to discuss its year-end earnings. The Annual Report Form 10K will be filed with the SEC by the end of the day on Thursday December 19, 2013.
Applied DNA Sciences, Inc. management will host a conference call beginning at 9:00 a.m. eastern standard time on Friday December 20, 2013 to discuss the company’s performance and outline key ongoing and future business initiatives. A presentation by CEO and President Dr. James Hayward and CFO Karol Kain Gray will be followed by a question-and-answer session.
All participants must pre-register using the link below. It is suggested that you log into the conference call approximately 10 minutes prior to the scheduled start time to ensure that all participants are on-line at the start of the call. While callers cannot be heard during the call, questions may be emailed beforehand to investor(at)adnas(dot)com.
For those of you unable to participate, a transcript of the call will be posted by end of business on December 20, 2013, and available under the “Investors” tab of the company’s web site.
Reserve your spot now at:
To Send Questions Prior to the Call:
Please email questions prior to the call to investor(at)adnas(dot)com.
Company Background Materials:
You may be interested in the company’s Investor Information section on the company’s web site, including publications, recent press releases, blogs, and other materials.
APDN is a provider of botanical-DNA based security and authentication solutions that can help identify and protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and DNAnet®, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.
The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2012 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/12Earnings_Call/prweb11433551.htm